ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
See our latest analysis for ResMed. That recent pullback, including a 7 day share price return of minus 2.21 percent and a 90 day share price return of minus 10.01 percent, looks more like cooling momentum than a broken story. This is particularly the case with the year to date share price still higher and multi year total shareholder returns remaining comfortably positive. If ResMed has you rethinking where healthcare growth could come from next, it might be worth scanning other quality names via our healthcare stocks With earnings still growing solidly and the share price trading below consensus targets, the key question now is whether ResMed is quietly undervalued or if the market has already priced in its next leg of growth. With ResMed last closing at $245.94 against a narrative fair value near $295, the valuation case leans supportive of the recent share price resilience. Ongoing innovation in product development including new releases of CPAP devices, mask interfaces
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed (NYSE:RMD) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.MarketBeat
- Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 [Seeking Alpha]Seeking Alpha
- ResMed (NYSE:RMD) was given a new $275.00 price target on by analysts at Robert W. Baird.MarketBeat
- ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Top 50 High-Quality Dividend Growth Stocks For December 2025 [Seeking Alpha]Seeking Alpha
RMD
Earnings
- 10/30/25 - Beat
RMD
Sec Filings
- 12/9/25 - Form 4
- 12/8/25 - Form 144
- 12/4/25 - Form 4
- RMD's page on the SEC website